世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038805

タンパク質治療薬の世界市場(2024-2028)

TechNavio

Global protein therapeutics market 2024-2028

発刊日 2024/05/20

言語英語

体裁PDF/191ページ

ライセンス/価格191ページ

0000038805

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

タンパク質治療薬市場は2023年から2028年に1,728億米ドル、予測期間中のCAGRは9.47%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。mAbに対する需要の増加、革新的技術を用いた新規療法の市場開発、有利な償還政策の利用可能性などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ モノクローナル抗体
      ◇ ヒトインスリン
      ◇ エリスロポエチン
      ◇ 凝固因子
      ◇ その他
    ➣ 用途別
      ◇ 代謝障害
      ◇ 免疫疾患
      ◇ 血液疾患
      ◇ がん
      ◇ 遺伝性疾患
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、今後数年間のタンパク質治療薬市場成長を牽引する主な要因の一つとして、タンパク質治療薬の改良に継続的に注力していることを挙げています。また、二重特異性抗体や多特異性抗体の出現や慢性疾患の増加は、市場の大きな需要につながります。

タンパク質治療薬市場に関するレポートは、次の分野をカバーしています。

  • タンパク質治療薬市場の規模
  • タンパク質治療薬市場の予測
  • タンパク質治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AstraZeneca Plc
    ➣ Bayer AG
    ➣ Boehringer Ingelheim International GmbH
    ➣ Cardinal Health Inc.
    ➣ Cipla Ltd.
    ➣ CV Sciences Inc.
    ➣ Endo International Plc
    ➣ GlaxoSmithKline Plc
    ➣ Medterra CBD
    ➣ Novartis AG
    ➣ Perrigo Co. Plc
    ➣ Pfizer Inc.
    ➣ Piramal Enterprises Ltd
    ➣ Reckitt Benckiser Group Plc,
    ➣ Sanofi
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.
    ➣ Weefsel Pharma
    ➣ AKUMS

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Protein Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Protein Therapeutics Market 2018 - 2022 ($ billion)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 mAbs - Market size and forecast 2023-2028
Chart on mAbs - Market size and forecast 2023-2028 ($ billion)
Data Table on mAbs - Market size and forecast 2023-2028 ($ billion)
Chart on mAbs - Year-over-year growth 2023-2028 (%)
Data Table on mAbs - Year-over-year growth 2023-2028 (%)
6.4 Human insulin - Market size and forecast 2023-2028
Chart on Human insulin - Market size and forecast 2023-2028 ($ billion)
Data Table on Human insulin - Market size and forecast 2023-2028 ($ billion)
Chart on Human insulin - Year-over-year growth 2023-2028 (%)
Data Table on Human insulin - Year-over-year growth 2023-2028 (%)
6.5 Erythropoeitin - Market size and forecast 2023-2028
Chart on Erythropoeitin - Market size and forecast 2023-2028 ($ billion)
Data Table on Erythropoeitin - Market size and forecast 2023-2028 ($ billion)
Chart on Erythropoeitin - Year-over-year growth 2023-2028 (%)
Data Table on Erythropoeitin - Year-over-year growth 2023-2028 (%)
6.6 Clotting factors - Market size and forecast 2023-2028
Chart on Clotting factors - Market size and forecast 2023-2028 ($ billion)
Data Table on Clotting factors - Market size and forecast 2023-2028 ($ billion)
Chart on Clotting factors - Year-over-year growth 2023-2028 (%)
Data Table on Clotting factors - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Market opportunity by Product ($ billion)
Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application
7.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
7.3 Metabolic disorders - Market size and forecast 2023-2028
Chart on Metabolic disorders - Market size and forecast 2023-2028 ($ billion)
Data Table on Metabolic disorders - Market size and forecast 2023-2028 ($ billion)
Chart on Metabolic disorders - Year-over-year growth 2023-2028 (%)
Data Table on Metabolic disorders - Year-over-year growth 2023-2028 (%)
7.4 Immunologic disorders - Market size and forecast 2023-2028
Chart on Immunologic disorders - Market size and forecast 2023-2028 ($ billion)
Data Table on Immunologic disorders - Market size and forecast 2023-2028 ($ billion)
Chart on Immunologic disorders - Year-over-year growth 2023-2028 (%)
Data Table on Immunologic disorders - Year-over-year growth 2023-2028 (%)
7.5 Hematological disorders - Market size and forecast 2023-2028
Chart on Hematological disorders - Market size and forecast 2023-2028 ($ billion)
Data Table on Hematological disorders - Market size and forecast 2023-2028 ($ billion)
Chart on Hematological disorders - Year-over-year growth 2023-2028 (%)
Data Table on Hematological disorders - Year-over-year growth 2023-2028 (%)
7.6 Cancer - Market size and forecast 2023-2028
Chart on Cancer - Market size and forecast 2023-2028 ($ billion)
Data Table on Cancer - Market size and forecast 2023-2028 ($ billion)
Chart on Cancer - Year-over-year growth 2023-2028 (%)
Data Table on Cancer - Year-over-year growth 2023-2028 (%)
7.7 Genetic disorders - Market size and forecast 2023-2028
Chart on Genetic disorders - Market size and forecast 2023-2028 ($ billion)
Data Table on Genetic disorders - Market size and forecast 2023-2028 ($ billion)
Chart on Genetic disorders - Year-over-year growth 2023-2028 (%)
Data Table on Genetic disorders - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity by geography ($ billion)
Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
12.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.8 Creative Biolabs
Creative Biolabs - Overview
Creative Biolabs - Product / Service
Creative Biolabs - Key offerings
12.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.11 Ipsen Pharma
Ipsen Pharma - Overview
Ipsen Pharma - Business segments
Ipsen Pharma - Key offerings
Ipsen Pharma - Segment focus
12.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.13 LGM Pharma LLC
LGM Pharma LLC - Overview
LGM Pharma LLC - Product / Service
LGM Pharma LLC - Key offerings
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
12.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 market analysis
market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Protein Therapeutics Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Product - Market share 2023-2028 (%)
Exhibits33: Data Table on Product - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Product
Exhibits35: Data Table on Comparison by Product
Exhibits36: Chart on mAbs - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on mAbs - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on mAbs - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on mAbs - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Human insulin - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on Human insulin - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on Human insulin - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Human insulin - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Erythropoeitin - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on Erythropoeitin - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on Erythropoeitin - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Erythropoeitin - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Clotting factors - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Clotting factors - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Clotting factors - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Clotting factors - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product ($ billion)
Exhibits57: Data Table on Market opportunity by Product ($ billion)
Exhibits58: Chart on Application - Market share 2023-2028 (%)
Exhibits59: Data Table on Application - Market share 2023-2028 (%)
Exhibits60: Chart on Comparison by Application
Exhibits61: Data Table on Comparison by Application
Exhibits62: Chart on Metabolic disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Metabolic disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Metabolic disorders - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Metabolic disorders - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Immunologic disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Data Table on Immunologic disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Chart on Immunologic disorders - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Immunologic disorders - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Hematological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits71: Data Table on Hematological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Chart on Hematological disorders - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Hematological disorders - Year-over-year growth 2023-2028 (%)
Exhibits74: Chart on Cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Data Table on Cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Chart on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits77: Data Table on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits78: Chart on Genetic disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Data Table on Genetic disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Chart on Genetic disorders - Year-over-year growth 2023-2028 (%)
Exhibits81: Data Table on Genetic disorders - Year-over-year growth 2023-2028 (%)
Exhibits82: Market opportunity by Application ($ billion)
Exhibits83: Data Table on Market opportunity by Application ($ billion)
Exhibits84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits85: Chart on Market share by geography 2023-2028 (%)
Exhibits86: Data Table on Market share by geography 2023-2028 (%)
Exhibits87: Chart on Geographic comparison
Exhibits88: Data Table on Geographic comparison
Exhibits89: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits114: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits115: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits117: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits118: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits119: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits120: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits121: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits122: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits123: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits124: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits125: Market opportunity by geography ($ billion)
Exhibits126: Data Tables on Market opportunity by geography ($ billion)
Exhibits127: Impact of drivers and challenges in 2023 and 2028
Exhibits128: Overview on criticality of inputs and factors of differentiation
Exhibits129: Overview on factors of disruption
Exhibits130: Impact of key risks on business
Exhibits131: Companies covered
Exhibits132: Matrix on companies position and classification
Exhibits133: AbbVie Inc. - Overview
Exhibits134: AbbVie Inc. - Product / Service
Exhibits135: AbbVie Inc. - Key news
Exhibits136: AbbVie Inc. - Key offerings
Exhibits137: Amgen Inc. - Overview
Exhibits138: Amgen Inc. - Product / Service
Exhibits139: Amgen Inc. - Key offerings
Exhibits140: AstraZeneca Plc - Overview
Exhibits141: AstraZeneca Plc - Product / Service
Exhibits142: AstraZeneca Plc - Key news
Exhibits143: AstraZeneca Plc - Key offerings
Exhibits144: Biogen Inc. - Overview
Exhibits145: Biogen Inc. - Product / Service
Exhibits146: Biogen Inc. - Key news
Exhibits147: Biogen Inc. - Key offerings
Exhibits148: Bristol Myers Squibb Co. - Overview
Exhibits149: Bristol Myers Squibb Co. - Product / Service
Exhibits150: Bristol Myers Squibb Co. - Key news
Exhibits151: Bristol Myers Squibb Co. - Key offerings
Exhibits152: Creative Biolabs - Overview
Exhibits153: Creative Biolabs - Product / Service
Exhibits154: Creative Biolabs - Key offerings
Exhibits155: Eli Lilly and Co. - Overview
Exhibits156: Eli Lilly and Co. - Product / Service
Exhibits157: Eli Lilly and Co. - Key news
Exhibits158: Eli Lilly and Co. - Key offerings
Exhibits159: F. Hoffmann La Roche Ltd. - Overview
Exhibits160: F. Hoffmann La Roche Ltd. - Business segments
Exhibits161: F. Hoffmann La Roche Ltd. - Key news
Exhibits162: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits163: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits164: Ipsen Pharma - Overview
Exhibits165: Ipsen Pharma - Business segments
Exhibits166: Ipsen Pharma - Key offerings
Exhibits167: Ipsen Pharma - Segment focus
Exhibits168: Johnson and Johnson Services Inc. - Overview
Exhibits169: Johnson and Johnson Services Inc. - Business segments
Exhibits170: Johnson and Johnson Services Inc. - Key news
Exhibits171: Johnson and Johnson Services Inc. - Key offerings
Exhibits172: Johnson and Johnson Services Inc. - Segment focus
Exhibits173: LGM Pharma LLC - Overview
Exhibits174: LGM Pharma LLC - Product / Service
Exhibits175: LGM Pharma LLC - Key offerings
Exhibits176: Novartis AG - Overview
Exhibits177: Novartis AG - Business segments
Exhibits178: Novartis AG - Key news
Exhibits179: Novartis AG - Key offerings
Exhibits180: Novartis AG - Segment focus
Exhibits181: Novo Nordisk AS - Overview
Exhibits182: Novo Nordisk AS - Business segments
Exhibits183: Novo Nordisk AS - Key offerings
Exhibits184: Novo Nordisk AS - Segment focus
Exhibits185: Pfizer Inc. - Overview
Exhibits186: Pfizer Inc. - Product / Service
Exhibits187: Pfizer Inc. - Key news
Exhibits188: Pfizer Inc. - Key offerings
Exhibits189: Sanofi SA - Overview
Exhibits190: Sanofi SA - Business segments
Exhibits191: Sanofi SA - Key news
Exhibits192: Sanofi SA - Key offerings
Exhibits193: Sanofi SA - Segment focus
Exhibits194: Inclusions checklist
Exhibits195: Exclusions checklist
Exhibits196: Currency conversion rates for US$
Exhibits197: Research methodology
Exhibits198: Information sources
Exhibits199: Data validation
Exhibits200: Validation techniques employed for market sizing
Exhibits201: Data synthesis
Exhibits202: 360 degree market analysis
Exhibits203: List of abbreviations

この商品のレポートナンバー

0000038805

TOP